Since there is an ever-going debate as to whether the complement system is pro- or anti-cancer, we aimed in the current study to investigate the expression pattern of two important complement regulatory proteins; CD46 and CD55 in ALL and AML cancer patients. Here, CD46 is linked to acute lymphoblastic leukemia.